C. Bulabois

R. Itzykson, A. Thiébaut-Bertrand, F. Garban, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC

I. Yakoub-Agha, M. Mohty, H. Avet-Loiseau, 2018, Bone Marrow Transplantation.

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

R. Fanin, F. Baron, M. Labopin, 2022, Bone Marrow Transplantation.

Impact of Cytogenetic Risk on Outcomes of Non-T Cell Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.

J. Esteve, R. Fanin, M. Labopin, 2022, Transplantation and cellular therapy.

Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

N. Kröger, M. Labopin, I. Yakoub-Agha, 2020, Bone Marrow Transplantation.

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC

M. Labopin, M. Robin, P. Chevallier, 2022, Bone Marrow Transplantation.

Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia.

H. Einsele, R. Fanin, N. Kröger, 2021, Clinical lymphoma, myeloma & leukemia.

Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation.

E. Deconinck, J. Cahn, D. Ducloux, 2005, Haematologica.

Salvage haploidentical or cord‐blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM‐TC

M. Robin, P. Chevallier, G. Guillerm, 2022, European journal of haematology.

Treatment of Relapse After Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome: A Large-Scale Study On Behalf of the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

M. Robin, I. Yakoub-Agha, D. Blaise, 2012 .

Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation

S. Bailly, Eléonore Kaphan, A. Thiébaut-Bertrand, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-T

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2016, Bone Marrow Transplantation.

Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study

M. Bernard, P. Chevallier, Y. Gruel, 2008, Haematologica.

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.

J. Cayuela, H. Dombret, S. Chevret, 2013, Blood.

Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease

A. Thiébaut, F. Stanke-Labesque, J. Tonini, 2012, Antimicrobial Agents and Chemotherapy.

Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques.

H. Fricker-Hidalgo, J. Timsit, J. Brion, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

P. Chevallier, I. Yakoub-Agha, J. Bay, 2021, Journal of Cancer Research and Clinical Oncology.

Improved Outcome in Young Children Compared to Adolescents and Adults After Allogeneic Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia: a Retrospective Study From Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) (SFGM-TC)

P. Chevallier, I. Yakoub-Agha, J. Bay, 2021 .

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

C. Schwebel, L. Chaperot, N. Sturm, 2019, Experimental Hematology & Oncology.

Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.

S. Chevret, P. Chevallier, I. Yakoub-Agha, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

P. Chevallier, D. Blaise, M. Mohty, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

M. Labopin, D. Blaise, A. Nagler, 2020, Journal of Hematology & Oncology.

Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study

I. Yakoub-Agha, P. Rohrlich, F. Barraco, 2018, Leukemia & lymphoma.

Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)

I. Yakoub-Agha, D. Blaise, M. Mohty, 2005, Bone Marrow Transplantation.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)].

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2014, Pathologie-biologie.

Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT

N. Kröger, S. Iacobelli, P. Chevallier, 2020, Bone Marrow Transplantation.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)].

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2014, Pathologie-biologie.

Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

D. Blaise, J. Golmard, P. Dreger, 2010, Haematologica.

Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire

M. Robin, P. Chevallier, D. Blaise, 2021, Bone Marrow Transplantation.

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

I. Yakoub-Agha, E. Tholouli, E. Deconinck, 2022, Haematologica.

Unusual increased beta-globulins in an elderly patient.

P. Faure, J. Renversez, B. Busser, 2011, Clinical chemistry.

Dynamics of Epstein‐Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy

A. Thiébaut, P. Morand, J. Cahn, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study

D. Miklos, I. Yakoub-Agha, B. Ko, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic Extracorporeal Photopheresis for Gvhd Prevention after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation from Identical Siblings and 10/10 HLA Unrelated Hematopoietic Stem Cells Donors

I. Yakoub-Agha, P. Rohrlich, F. Barraco, 2014 .

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Robin, I. Yakoub-Agha, M. Mohty, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.

M. Robin, P. Chevallier, G. Guillerm, 2023, Transplantation and cellular therapy.

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Arnon Nagler, Myriam Labopin, M. Labopin, 2015, Haematologica.

A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity

R. Bataille, P. Moreau, B. Mahé, 1996, British journal of haematology.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT

J. Esteve, A. Ganser, J. Bourhis, 2021, Blood.

How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndrome.

P. Chevallier, A. Bazarbachi, C. Pautas, 2017, Current research in translational medicine.

Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3‐ITD molecular status for cytogenetically normal AML patients: A GOELAMS study

P. Chevallier, M. Béné, C. Récher, 2012, American journal of hematology.

Adult patients with de novo acute myeloid leukemia show a functional deregulation of redox balance at diagnosis which is correlated with molecular subtypes and overall survival

R. Gressin, A. Thiébaut, P. Faure, 2019, Haematologica.

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial

M. Bernard, G. Guillerm, C. Récher, 2021, European journal of haematology.

Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

P. Chevallier, I. Yakoub-Agha, G. Guillerm, 2023, Bone Marrow Transplantation.

Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—The DIADEM study from the chronic malignancies working party of the EBMT

I. Yakoub-Agha, J. Snowden, M. Sever, 2019, Bone Marrow Transplantation.

HLA‐DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation

R. Porcher, P. van Endert, P. Chevallier, 2018, American journal of hematology.

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

M. Bernard, M. Béné, L. Fornecker, 2020, Leukemia.

Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, J. Bay, 2020, Fundamental & clinical pharmacology.

Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

P. Galieni, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial

J. Cayuela, A. Vekhoff, P. Cony-Makhoul, 2021, Leukemia.

Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP‐EBMT study

I. Yakoub-Agha, E. Deconinck, M. Itälä-Remes, 2023, European journal of haematology.

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

H. Lanic, P. Chevallier, M. Mohty, 2021, Blood.

[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].

P. Chevallier, I. Yakoub-Agha, A. Bazarbachi, 2017, Bulletin du cancer.

Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post‐transplant cyclophosphamide in AML in first complete remission

M. Labopin, I. Yakoub-Agha, D. Blaise, 2023, British journal of haematology.

Randomized Phase 2 Trial of Lirilumab (anti-KIR monoclonal antibody, mAb) As Maintenance Treatment in Elderly Patients (pts) with Acute Myeloid Leukemia (AML): Results of the Effikir Trial

H. Dombret, D. Olive, S. Leprêtre, 2017 .

Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT

R. Fanin, M. Labopin, D. Blaise, 2023, HemaSphere.

Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy

L. Fornecker, C. Récher, K. Laribi, 2022, Cancer Medicine.

Gene Mutations and Minimal Residual Disease (MRD) As Predictors of Remission Duration in Adults with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Treated with High-Dose Cytarabine (HDAC) - First Results of the Prospective French Intergroup CBF-2006 Trial

J. Cayuela, H. Dombret, M. Béné, 2011 .

On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

M. Robin, P. Chevallier, I. Yakoub-Agha, 2023, Acta Haematologica.

Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-Asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study.

M. Bernard, Y. Gruel, N. Ifrah, 2004 .

Interest of Non-Myeloablative Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma: A Multicenter Retrospective Study.

I. Yakoub-Agha, A. Nagler, M. Mohty, 2008 .

F. Stanke-Labesque, J. Quesada, E. Gautier‐Veyret, 2015, Antimicrobial Agents and Chemotherapy.

Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques.

H. Fricker-Hidalgo, J. Timsit, J. Brion, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful and Safe Treatment of Intestinal Graft-Versus-Host Disease (GvHD) with Pooled-Donor Full Ecosystem Microbiota Biotherapeutic: Results from a 29 Patient-Cohort of a Compassionate Use/Expanded Access Treatment Program

M. Mohty, R. Devillier, J. Cornillon, 2020 .

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial

M. Labopin, D. Blaise, M. Mohty, 2024, Blood cancer journal.

Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor

E. Forcade, H. Finel, A. Boumendil, 2024, Bone marrow transplantation.

Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT.

M. Mohty, A. Bazarbachi, T. Gedde-Dahl, 2024, Bone marrow transplantation.

Adult patients with de novo acute myeloid leukemia show a functional deregulation of redox balance at diagnosis which is correlated with molecular subtypes and overall survival

R. Gressin, A. Thiébaut, P. Faure, 2019, Haematologica.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)].

D. Blaise, J. Bay, J. Eliaou, 2014, Pathologie-biologie.

Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial

P. Chevallier, M. Mohty, T. Cluzeau, 2023, EClinicalMedicine.

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2015, European journal of haematology.

Mobile air-decontamination unit and filamentous fungal load in the hematology ward: how efficient at the low-activity mode?

B. Lebeau, M. Mallaret, R. Grillot, 2009, American journal of infection control.

Remission of a long-lasting sarcoidosis after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

B. Balme, F. Skowron, B. Anglaret, 2016, JAAD case reports.